Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00390_DB01157_nanopub.RArfTUbH4ZmPQ-WBYtyqVVDA_gtYB_xR4U36r2B-MH49Y#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00390_DB01157 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00390_DB01157 label "DDI between Digoxin and Trimetrexate - The absorption of Digoxin, a cardiac glycoside, may be decreased by antineoplastic agents such as Trimetrexate. Liquid forms of Digoxin do not appear to be significantly affected. Monitor Digoxin tablet efficacy if Trimetrexate therapy is initiated, discontinued or if the dose is altered. [drugbank_resource:DB00390_DB01157]" assertion.
- drugbank_resource:DB00390_DB01157 identifier "drugbank_resource:DB00390_DB01157" assertion.
- drugbank_resource:DB00390_DB01157 title "DDI between Digoxin and Trimetrexate - The absorption of Digoxin, a cardiac glycoside, may be decreased by antineoplastic agents such as Trimetrexate. Liquid forms of Digoxin do not appear to be significantly affected. Monitor Digoxin tablet efficacy if Trimetrexate therapy is initiated, discontinued or if the dose is altered." assertion.
- drugbank:DB00390 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB01157 assertion.
- drugbank:DB01157 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB01157 assertion.